13F-HR filed by Lynx1 Capital Management LP
Lynx1 Capital Management LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 13 holding rows worth $119,949,321.
- Accession
- 0001892688-23-000045
- Filer
- CIK 1910456
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 13 entries on the cover page, a total value of $119,949,321 stated on the cover page (in dollars after the unit check, H1), rows summing to $119,949,321 with VALUE read as dollars as filed, 13F file number 028-22151. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerLynx1 Capital Advisors LLC028-22145
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 3,136,173 | $24,211,256 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 2,454,627 | $20,299,765 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 1,067,723 | $19,646,103 | dollars as filed | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 2,214,250 | $13,839,063 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,369,927 | $11,945,763 | dollars as filed | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 7,067,718 | $6,898,093 | dollars as filed | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 761,258 | $6,759,971 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 866,646 | $6,239,851 | dollars as filed | |
| PARDES BIOSCIENCES INC | 69945Q105 | COM | 3,324,061 | $4,387,761 | dollars as filed | |
| PASSAGE BIO INC | 702712100 | COM | 3,407,598 | $3,263,457 | dollars as filed | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 2,428,323 | $1,699,826 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 23,000 | $547,170 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 26,225 | $211,242 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001892688-23-000045 | this filing | 2023-05-15 | acceptance time not in the bulk data set |